Fagron NV (FAGR.BR) — Technical state
As of 2026-11-02 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Closelooknet score: 54 out of 100 (momentum 60 · quality 56 · valuation 58), as of 2026-11-03.
- Signal: Recovery attempt under the 200-day — Trades +4.7% vs the 50-day and +3.1% vs the 200-day average, 6.9% below the 52-week high and +19.7% off the 52-week low; a death cross printed 31 sessions ago. Computed from daily closes. (as of 2026-11-02)
- Trend: Fagron NV trades 4.7% above its 50-day and 3.1% above its 200-day moving average. (as of 2026-11-02)
Fagron NV compounds and personalises pharmaceutical treatments for hospitals, pharmacies, clinics and patients worldwide, working through three segments: Essentials, Brands and Compounding Services. Its product range spans capsule and tablet excipients, dermatology and scar-care formulations, hair-loss treatments and a paediatric suspension base, alongside training for prescribers and pharmacists through its own academy.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the FAGR.BR overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.
Trades +4.7% vs the 50-day and +3.1% vs the 200-day average, 6.9% below the 52-week high and +19.7% off the 52-week low; a death cross printed 31 sessions ago. Computed from daily closes.
The moving-average stack
- vs 20-day+1.9%
- vs 50-day+4.7%
- vs 200-day+3.1%
- 52-week band6.9% off the high · +19.7% off the low
- Streak2 consecutive up sessions
- CrossoverDeath cross 31 sessions ago
- 50-day crossprice crossed up through the 50-day 13 sessions ago
- Stochastic%K 72 · %D 76.9
Continue: the FAGR.BR chart & overview · quality & forensics · the signal board
FAQ · from the current data · as of 2026-11-02
Quick answers
What is the current Closelooknet signal on FAGR.BR?
Recovery attempt under the 200-day — Trades +4.7% vs the 50-day and +3.1% vs the 200-day average, 6.9% below the 52-week high and +19.7% off the 52-week low; a death cross printed 31 sessions ago. Computed from daily closes. As of 2026-11-02; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is FAGR.BR above its 50-day and 200-day moving averages?
As of 2026-11-02, Fagron NV trades +4.7% above its 50-day and +3.1% above its 200-day average, with the 20-day +1.9% away.
How far is FAGR.BR from its 52-week high?
6.9% below the 52-week high and 19.7% above the 52-week low, as of 2026-11-02.
Related in the Closelooknet universe
then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ROVI.MC Laboratorios Farmaceuticos ROVIindustry
- LNTH Lantheus Holdings Incindustry
- GALDY GALDERMA GROUP AGindustry
- KNSA Kiniksa Pharmaceuticals Ltdindustry
- ALM.MC Almirall S.A.industry
- IRWD Ironwood Pharmaceuticals Incindustry
- BHC.TO Bausch Health Companies Incindustry
- PCRX Pacira BioSciences, Inc.industry
- HLUN-B.CO H Lundbeck A/Sindustry
- UTHR United Therapeutics Corporationindustry
- VETO.PA Vetoquinolindustry
- XERS Xeris Pharmaceuticals Incindustry
- AMPH Amphastar Pindustry
- GUD.TO Knight Therapeutics Inc.industry
- VTRS Viatris Incindustry
- 000538.SHE Yunnan Baiyao Group Co Ltdindustry
- PRGO Perrigo Company PLCindustry
- ELAN Elanco Animal Healthindustry
- FAE.MC Faes Farma SAindustry
- INDV Indivior PLC Ordinary Sharesindustry